Olema Pharmaceuticals Inc (OLMA) returns
Olema Pharmaceuticals returns over 5 years
$1,000 invested in Olema Pharmaceuticals five years ago was worth $259.26 at the close on October 30, 2026, with dividends reinvested: an average return of -23.7% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -19.0% | — | $810.19 | -0.9% |
| 3 months | -40.8% | — | $592.22 | +2.1% |
| Year to date | -72.0% | — | $280.00 | +11.7% |
| 1 year | -20.3% | — | $797.27 | +12.4% |
| 3 years | -47.2% | -19.2% | $527.90 | +88.5% |
| 5 years | -74.1% | -23.7% | $259.26 | +76.0% |
Olema Pharmaceuticals return by calendar year
| Year | OLMA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -72.0% | +11.7% | -83.7% |
| 2025 | +328.8% | +17.7% | +311.1% |
| 2024 | -58.4% | +24.9% | -83.3% |
| 2023 | +472.7% | +26.2% | +446.5% |
| 2022 | -73.8% | -18.2% | -55.7% |
| 2021 | -80.5% | +28.7% | -109.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Olema Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.